Jardiance
empagliflozin
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor, pharmacist or nurse.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What Jardiance is and what it is used for
What you need to know before you take Jardiance
How to take Jardiance
Possible side effects
How to store Jardiance
Contents of the pack and other information
Jardiance contains the active substance empagliflozin.
Jardiance is a member of a group of medicines called sodium glucose co-transporter-2 (SGLT2) inhibitors.
Jardiance is used to treat type 2 diabetes in adult patients (aged 18 years and older) that cannot be controlled by diet and exercise alone.
Jardiance can be used without other medicines in patients who cannot take metformin (another diabetes medicine).
Jardiance can also be used with other medicines for the treatment of diabetes. These may be medicines taken by mouth or given by injection such as insulin.
Jardiance works by blocking the SGLT2 protein in your kidneys. This causes blood sugar (glucose) to be removed in your urine. Thereby Jardiance lowers the amount of sugar in your blood.
This medicine can also help prevent heart disease in patients with type 2 diabetes mellitus.
It is important that you continue with your diet and exercise plan as told by your doctor, pharmacist or nurse.
Jardiance is used to treat heart failure in adult patients with symptoms due to impaired heart function.
Type 2 diabetes is a disease that comes from both your genes and your lifestyle. If you have type 2 diabetes, your pancreas does not make enough insulin to control the level of glucose in your blood,
and your body is unable to use its own insulin effectively. This results in high levels of glucose in your blood which can lead to medical problems like heart disease, kidney disease, blindness, and poor circulation in your limbs.
Heart failure occurs when the heart is too weak or stiff and cannot work properly. This can lead to serious medical problems and need for hospital care. The most common symptoms of heart failure are feeling breathless, feeling tired or very tired all the time, and ankle swelling.
Jardiance helps protect your heart from getting weaker and improves your symptoms.
if you are allergic to empagliflozin or any of the other ingredients of this medicine (listed in section 6).
Ketoacidosis
if you experience rapid weight loss, feeling sick or being sick, stomach pain, excessive thirst, fast and deep breathing, confusion, unusual sleepiness or tiredness, a sweet smell to your breath, a sweet or metallic taste in your mouth, or a different odour to your urine or sweat, contact a doctor or the nearest hospital straight away. These symptoms could be a sign of “ketoacidosis”
– a rare, but serious, sometimes life-threatening problem you can get with diabetes because of increased levels of “ketone bodies” in your urine or blood, seen in tests. The risk of developing ketoacidosis may be increased with prolonged fasting, excessive alcohol consumption, dehydration, sudden reductions in insulin dose, or a higher need of insulin due to major surgery or serious illness.
if you have “type 1 diabetes”. This type usually starts when you are young and your body does not produce any insulin. You should not take Jardiance if you have type 1 diabetes.
if you have serious kidney problems – your doctor may limit your dose to 10 mg once a day or ask you to take a different medicine (see also section 3, ‘How to take Jardiance’).
if you have serious liver problems – your doctor may ask you to take a different medicine.
might be at risk of dehydration, for example:
if you are being sick, have diarrhoea or fever, or if you are not able to eat or drink
if you are taking medicines that increase urine production [diuretics] or lower blood pressure
if you are 75 years old or older.
Possible signs are listed in section 4 under ‘dehydration’. Your doctor may ask you to stop taking Jardiance until you recover to prevent loss of too much body fluid. Ask about ways to prevent dehydration.
if you have a serious infection of the kidney or the urinary tract with fever. Your doctor may ask you to stop taking Jardiance until you have recovered.
Talk to your doctor immediately if you develop a combination of symptoms of pain, tenderness, redness, or swelling of the genitals or the area between the genitals and the anus with fever or feeling generally unwell. These symptoms could be a sign of a rare but serious or even life-threatening infection, called necrotising fasciitis of the perineum or Fournier´s gangrene which destroys the tissue under the skin. Fournier’s gangrene has to be treated immediately.
Foot care
Like for all diabetic patients it is important to check your feet regularly and adhere to any other advice regarding foot care given by your health care professional.
Kidney function
Your kidneys should be checked before you start taking and whilst you are on this medicine.
Urine glucose
Because of how this medicine works, your urine will test positive for sugar while you are taking this medicine.
Jardiance is not recommended for children and adolescents under 18 years, because it has not been studied in these patients.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
It is important to tell your doctor:
if you are taking medicines that increase urine production (diuretics). Your doctor may ask you to stop taking Jardiance. Possible signs of losing too much fluid from your body are listed in section 4.
if you are taking other medicines that lower the amount of sugar in your blood such as insulin or a “sulphonylurea” medicine. Your doctor may want to lower the dose of these other medicines, to prevent your blood sugar levels from getting too low (hypoglycaemia).
if you are taking lithium because Jardiance can lower the amount of lithium in your blood.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Do not use Jardiance if you are pregnant. It is unknown if Jardiance is harmful to the unborn child. Do not use Jardiance if you are breast-feeding. It is not known if Jardiance passes into human breast milk.
Jardiance has minor influence on the ability to drive and use machines.
Taking this medicine in combination with medicines called sulphonylureas or with insulin can cause blood sugar levels to drop too low (hypoglycaemia), which may cause symptoms such as shaking, sweating and change in vision, and may affect your ability to drive and use machines. Do not drive or use any tools or machines, if you feel dizzy while taking Jardiance.
Jardiance contains lactose (milk sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium free’.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose of Jardiance is one 10 mg tablet once a day. If you have type 2 diabetes mellitus, your doctor will decide whether to increase your dose to 25 mg once a day, if needed to help to control your blood sugar.
Your doctor may limit your dose to 10 mg once a day if you have a kidney problem.
Your doctor will prescribe the strength that is right for you. Do not change your dose unless your doctor has told you to.
Swallow the tablet whole with water
You can take the tablet with or without food
You can take the tablet at any time of the day. However, try to take it at the same time each day. This will help you to remember to take it.
If you have type 2 diabetes mellitus, your doctor may prescribe Jardiance together with another diabetes medicine. Remember to take all medicines as directed by your doctor to achieve the best results for your health.
Appropriate diet and exercise help your body use its blood sugar better. It is important to stay on the diet and exercise program recommended by your doctor while taking Jardiance.
If you take more Jardiance than you should, talk to a doctor immediately or go to a hospital immediately. Take the medicine pack with you.
What to do if you forget to take a tablet depends on how long it is until your next dose.
If it is 12 hours or more until your next dose, take Jardiance as soon as you remember. Then take your next dose at the usual time.
If it is less than 12 hours until your next dose, skip the missed dose. Then take your next dose at the usual time.
Do not take a double dose of Jardiance to make up for a forgotten dose.
Do not stop taking Jardiance without first consulting your doctor. If you have type 2 diabetes mellitus, your blood sugar levels may increase when you stop taking Jardiance.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Possible signs of severe allergic reaction may include:
swelling of the face, lips, mouth, tongue, or throat that may lead to difficulty breathing or swallowing)
These are the signs of diabetic ketoacidosis (see also section 2, ‘Warnings and precautions’):
increased levels of “ketone bodies” in your urine or blood
rapid weight loss
feeling sick or being sick
stomach pain
excessive thirst
fast and deep breathing
confusion
unusual sleepiness or tiredness
a sweet smell to your breath, a sweet or metallic taste in your mouth or a different odour to your urine or sweat.
This may occur regardless of blood glucose level. Your doctor may decide to temporarily or permanently stop your treatment with Jardiance.
If you take Jardiance with another medicine that can cause low blood sugar, such as a sulphonylurea or insulin, your risk of getting low blood sugar is higher. The signs of low blood sugar may include:
shaking, sweating, feeling very anxious or confused, fast heart beat
excessive hunger, headache
Your doctor will tell you how to treat low blood sugar levels and what to do if you get any of the signs above. If you have symptoms of low blood sugar, eat glucose tablets, a high sugar snack or drink fruit juice. Measure your blood sugar if possible and rest.
The signs of urinary tract infection are:
burning sensation when passing urine
urine that appears cloudy
pain in the pelvis, or mid-back pain (when kidneys are infected)
An urge to pass urine or more frequent urination may be due to the way Jardiance works, but they can also be signs of urinary tract infection. If you note an increase in such symptoms, you should also contact your doctor.
The signs of dehydration are not specific, but may include:
unusual thirst
lightheadedness or dizziness upon standing
fainting or loss of consciousness
Common
genital yeast infection (thrush)
passing more urine than usual or needing to pass urine more often
itching
rash or red skin – this may be itchy and include raised bumps, oozing fluid or blisters
thirst
blood tests may show an increase in blood fat (cholesterol) levels in your blood
constipation
Uncommon
hives
straining or pain when emptying the bladder
blood tests may show a decrease in kidney function (creatinine or urea)
blood tests may show increases in the amount of red blood cells in your blood (haematocrit)
Rare
necrotising fasciitis of the perineum or Fournier´s gangrene, a serious soft tissue infection of the genitals or the area between the genitals and the anus
Very Rare
inflammation of the kidneys (tubulointerstitial nephritis)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after ‘EXP’. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is empagliflozin.
Each tablet contains 10 mg or 25 mg empagliflozin.
The other ingredients are:
tablet core: lactose monohydrate (see end of section 2 under ‘Jardiance contains lactose’), microcrystalline cellulose, hydroxypropylcellulose, croscarmellose sodium (see end of section 2 under ‘Jardiance contains sodium’), colloidal anhydrous silica, magnesium stearate
film-coating: hypromellose, titanium dioxide (E171), talc, macrogol (400), iron oxide yellow (E172)
Jardiance 10 mg film-coated tablets are round, pale yellow, biconvex and bevel-edged. They have “S10” on one side and the Boehringer Ingelheim logo on the other side. The tablets are 9.1 mm in diameter.
Jardiance 25 mg film-coated tablets are oval, pale yellow and biconvex. They have “S25” on one side and the Boehringer Ingelheim logo on the other side. The tablet is 11.1 mm long and has a width of
5.6 mm.
Jardiance tablets are available in PVC/aluminium perforated unit dose blisters. The pack sizes are 7 x 1, 10 x 1, 14 x 1, 28 x 1, 30 x 1, 60 x 1, 70 x 1, 90 x 1, and 100 x 1 film-coated tablets.
Not all pack sizes may be marketed in your country.
55216 Ingelheim am Rhein Germany
Boehringer Ingelheim Pharma GmbH & Co. KG Binger Strasse 173
55216 Ingelheim am Rhein Germany
Boehringer Ingelheim Hellas Single Member S.A. 5th km Paiania – Markopoulo
Koropi Attiki, 19441 Greece
Rottendorf Pharma GmbH Ostenfelder Strasse 51 – 61
59320 Ennigerloh Germany
Boehringer Ingelheim France 100-104 Avenue de France 75013 Paris
France
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
SCS Boehringer Ingelheim Comm.V Tél/Tel: +32 2 773 33 11
Boehringer Ingelheim RCV GmbH & Co KG Lietuvos filialas
Tel: +370 5 2595942
Бьорингер Ингелхайм РЦВ ГмбХ и Ко. КГ - клон България
Тел: +359 2 958 79 98
SCS Boehringer Ingelheim Comm.V Tél/Tel: +32 2 773 33 11
Boehringer Ingelheim spol. s r.o. Tel: +420 234 655 111
Boehringer Ingelheim RCV GmbH & Co KG Magyarországi Fióktelepe
Tel: +36 1 299 89 00
Boehringer Ingelheim Danmark A/S Tlf: +45 39 15 88 88
Boehringer Ingelheim Ireland Ltd. Tel: +353 1 295 9620
Boehringer Ingelheim Pharma GmbH & Co. KG Tel: +49 (0) 800 77 90 900
Boehringer Ingelheim b.v. Tel: +31 (0) 800 22 55 889
Lilly Deutschland GmbH Tel. +49 (0) 6172 273 2222
Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal
Tel: +372 612 8000
Boehringer Ingelheim Norway KS Tlf: +47 66 76 13 00
Boehringer Ingelheim Ελλάς Μονοπρόσωπη A.E. Tηλ: +30 2 10 89 06 300
Boehringer Ingelheim RCV GmbH & Co KG Tel: +43 1 80 105-7870
Boehringer Ingelheim España, S.A. Tel: +34 93 404 51 00
Boehringer Ingelheim Sp. z o.o. Tel: +48 22 699 0 699
Lilly S.A.
Tel: +34 91 663 50 00
Boehringer Ingelheim France S.A.S. Tél: +33 3 26 50 45 33
Boehringer Ingelheim Portugal, Lda. Tel: +351 21 313 53 00
Lilly France SAS
Tél: +33 1 55 49 34 34
Lilly Portugal Produtos Farmacêuticos, Lda Tel: +351 21 412 66 00
Boehringer Ingelheim Zagreb d.o.o. Tel: +385 1 2444 600
Boehringer Ingelheim RCV GmbH & Co KG Viena - Sucursala Bucureşti
Tel: +40 21 302 28 00
Boehringer Ingelheim Ireland Ltd. Tel: +353 1 295 9620
Boehringer Ingelheim RCV GmbH & Co KG Podružnica Ljubljana
Tel: +386 1 586 40 00
Eli Lilly and Company (Ireland) Limited Tel: +353 1 661 4377
Vistor hf.
Sími: +354 535 7000
Boehringer Ingelheim RCV GmbH & Co KG organizačná zložka
Tel: +421 2 5810 1211
Boehringer Ingelheim Italia S.p.A. Tel: +39 02 5355 1
Boehringer Ingelheim Finland Ky Puh/Tel: +358 10 3102 800
Eli Lilly Italia S.p.A. Tel: +39 05 5425 71
Boehringer Ingelheim Ελλάς Μονοπρόσωπη A.E. Tηλ: +30 2 10 89 06 300
Boehringer Ingelheim AB Tel: +46 8 721 21 00
Boehringer Ingelheim RCV GmbH & Co KG Latvijas filiāle
Tel: +371 67 240 011
Boehringer Ingelheim Ireland Ltd. Tel: +353 1 295 9620
Eli Lilly and Company (Ireland) Limited Tel: +353 1 661 4377